Cammarata Sue 4

4 · MELINTA THERAPEUTICS, INC. /NEW/ · Filed May 20, 2019

Insider Transaction Report

Form 4
Period: 2019-05-16
Cammarata Sue
Chief Medical Officer
Transactions
  • Award

    Restricted Stock Units

    2019-05-16+120,000120,000 total
    Exercise: $0.00Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]The restricted stock units will vest in equal semi-annual installments over the two year period following May 16, 2019, subject to Ms. Cammarata's continued service with the Issuer through the applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION